"TOTALL stands for Treat tO Target And Live Longer. And true to our name we strive to provide comprehensive and scientific care to patient with Diabetes, Thyroid disease and Hormonal ailments. Dr Sunil M Jain's TOTALL Diabetes Hormone Institute is central India’s largest institution dedicated exclusively to provide highest level of expert consultation and care in the field of Diabetes, Thyroid and Hormonal problems. TOTALL help you to help yourself. We believe in rendering highest quality of care with personalized human touch. We understand that each patient and his needs are unique and hence our treatment plans are truly individualized."

During the past decade, TOTALL Diabetes Hormone Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "TOTALL Diabetes Hormone Institute" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Glenmark Pharmaceuticals S.A." with 1 trials as a collaborator and "Medtronic" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "TOTALL Diabetes Hormone Institute" are "Diabetes Mellitus, Type 2" (2 trials), "Growth Hormone Deficiency" (1 trials) and "Painful Diabetic Peripheral Neuropathy" (1 trials). Many other conditions were trialed in "TOTALL Diabetes Hormone Institute" in a lesser frequency.

Most popular intervention types in "TOTALL Diabetes Hormone Institute" are "Drug" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "GRC 17356" (1 trials), "Genotropin" (1 trials), "Matching Placebo" (1 trials), "Zomacton" (1 trials) and "glimepiride" (1 trials). Other intervention names were less common.

The vast majority of trials in "TOTALL Diabetes Hormone Institute" are 4 trials for "All" genders.

Currently, there are NaN active trials in "TOTALL Diabetes Hormone Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in TOTALL Diabetes Hormone Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in TOTALL Diabetes Hormone Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".